SCHEMBL30912166

SCHEMBL30912166

Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@H](C)[C@](C)(N)C(=O)O)c(C)c34)ccc2[nH]1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDR P35968 16/20 0.74
▸ CYP3A4 P08684 12/20 0.74
▸ FGFR1 P11362 5/20 0.74
▸ KCNH2 Q12809 3/20 0.74
▸ STK10 O94804 2/20 0.74
▸ MAP4K4 O95819 2/20 0.74
▸ RET P07949 2/20 0.74
▸ PDGFRB P09619 2/20 0.74
▸ DDR1 Q08345 2/20 0.74
▸ SLK Q9H2G2 2/20 0.74
▸ EPHB6 O15197 1/20 0.74
▸ RIPK2 O43353 1/20 0.74
▸ ABL1 P00519 1/20 0.74
▸ EGFR P00533 1/20 0.74
▸ LCK P06239 1/20 0.74
▸ CSF1R P07333 1/20 0.74
▸ HCK P08631 1/20 0.74
▸ KIT P10721 1/20 0.74
▸ SRC P12931 1/20 0.74
▸ PDGFRA P16234 1/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2263514 1.00 KDR (0.74) KDRCYP3A4FGFR1KCNH2STK10
SCHEMBL20538934 1.00 KDR (0.74) KDRCYP3A4FGFR1KCNH2STK10
SCHEMBL18825560 1.00 KDR (0.74) KDRCYP3A4FGFR1KCNH2STK10
Alanine SCHEMBL2729838 0.97 CYP3A4 (0.73) KDRCYP3A4FGFR1KCNH2STK10
Brivanib SCHEMBL29354510 0.85 KDR (1.00) KDRCYP3A4FGFR1KCNH2STK10
Brivanib SCHEMBL1227111 0.85 KDR (1.00) KDRCYP3A4FGFR1KCNH2STK10
SCHEMBL1227534 0.85 KDR (0.83) KDRCYP3A4FGFR1KCNH2STK10
Brivanib SCHEMBL1227589 0.85 KDR (1.00) KDRCYP3A4FGFR1KCNH2STK10
Brivanib SCHEMBL1227112 0.85 KDR (1.00) KDRCYP3A4FGFR1KCNH2STK10
SCHEMBL17377930 0.85 CYP3A4 (0.76) KDRCYP3A4FGFR1KCNH2STK10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112261970-B 3- (5-Hydroxy-1-oxo-isoindolin-2-yl) piperidine-2, 6-dione derivatives and their use in the treatment of IKAROS family zinc finger 2 (IKZF 2) dependent diseases 诺华股份有限公司 2025-02-07 — — CN disclosed
CN-116134027-B Heteroaryl-substituted 3- (1-oxo-isoindolin-2-yl) piperidine-2, 6-dione derivatives and uses thereof 诺华股份有限公司 2025-01-24 — — CN disclosed
CN-119241499-A 3- (5-Hydroxy-1-oxo-isoindolin-2-yl) piperidine-2, 6-dione derivatives and uses thereof 诺华股份有限公司 2025-01-03 — — CN disclosed
CN-112334194-B 3- (5-Amino-1-oxo-isoindolin-2-yl) piperidine-2, 6-dione derivatives and their use in the treatment of I KAROS family zinc finger 2 (IKZF 2) dependent diseases 诺华股份有限公司 2024-12-06 — — CN disclosed
CN-113490528-B 3- (1-Oxo-5- (piperidin-4-yl) isoindolin-2-yl) piperidine-2, 6-dione derivatives and uses thereof 诺华股份有限公司 2024-12-03 — — CN disclosed
CN-113329792-B Substituted 3- (1-oxo-isoindolin-2-yl) piperidine-2, 6-dione derivatives and uses thereof 诺华股份有限公司 2024-06-28 — — CN disclosed
Send feedback